Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring, and commercializing differentiated and accessible medicines that address unmet medical needs. Founded in 2008, the company has been incredibly successful.
Starting with one product, the company now has nine products and annual revenues of more than US $1 billion. However, a number of acquisitions resulted in several disparate financial systems held together by Microsoft Excel.
According to Michelle Parson, senior vice president of financial planning and analysis, “Digital transformation was important to Horizon Pharma due to the inorganic growth we’ve seen over the last few years.”
Working with Accenture, Horizon Pharma started its transformation by moving multiple general ledgers to a single digital finance solution. With this solution, the finance department now has a single source of information, which has enabled the organization to significantly reduce the time it takes to complete its monthly reporting.
“There was a time when it would take more than 30 days,” said Michelle. “Today we can do it pretty much within seven days. So it’s been a big win across our finance organization.”
Using the software has removed complexity and streamlined the different processes. As a result, finance professionals are more efficient in their jobs. The solution is also completely scalable, which is important to Horizon Pharma, as Michelle explains.
“We have an M&A strategy, and in order to be able to do that in a timely manner, we need a platform that will be able to grow with us and scale. We now have that capability.”